Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
No of Pages: 69
WEBSITE
Single User License: US$ 2500 Corporate User License: US$ 4000
www.rnrmarketresearch.com
Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020 

The analysts forecast global PVA drugs market to grow at a CAGR of 7.13% during the period 2016-2020. Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of postmenopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA. This report covers the present scenario and the growth prospects of the global PVA drugs market for 20152020. To calculate the market size, the report considers revenue generated from the sales of drugs (creams, tablets, patches, and rings) used to treat PVA.
View Complete Report @ http://www.rnrmarketresearch.com/global-deep-brain-stimulation-market-2016-2020market-report.html?utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO
Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
The report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=534735&utm_source=Fpro&utm_medium=P romotion&utm_campaign=SEO
Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
The report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors : Pfizer Inc., Allergan Inc., Shionogi & Co. Ltd., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd.
Other prominent vendors : Bayer, Bionovo, EndoCeutics, Foamix Pharmaceuticals, Ligand Pharmaceuticals, Pantarhei Bioscience, Pep-Tonic Medical, TherapeuticsMD, Upsher-Smith Laboratories
Market driver - Favorable healthcare reforms in the US
Market challenge - Patent expiry of branded products
Market trend - Paradigm shift to non-estrogenic therapies
Inquire on the Report http://www.rnrmarketresearch.com/contacts/inquire-beforebuying?rname=534735&utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO
Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=534735&utm_source=Fpro&utm_medium=Pr motion&utm_campaign=SEO
RNR MARKET RESEARCH RNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact : sales@rnrmarketresearch.Com / +18883915441
FOLLOW US
Website
www.rnrmarketresearch.com